These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 2018049

  • 41. Acquired immune deficiency syndrome-related Kaposi's sarcoma.
    Krown SE.
    J Clin Oncol; 1991 Dec; 9(12):2235-7. PubMed ID: 1960565
    [No Abstract] [Full Text] [Related]

  • 42. [Recombinant granulocyte colony-stimulating factor in the long-term treatment of AIDS-related neutropenias].
    Garavelli PL, Berti P.
    Recenti Prog Med; 1993 Dec; 84(7-8):526-30. PubMed ID: 8356307
    [Abstract] [Full Text] [Related]

  • 43. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
    Mathé G, Pontiggia P, Orbach-Arbouys S, Triana K, Ambetima N, Morette C, Hallard M, Blanquet D.
    Biomed Pharmacother; 1996 Dec; 50(5):220-7. PubMed ID: 8949403
    [Abstract] [Full Text] [Related]

  • 44. Targeted therapy of human immunodeficiency virus-related disease.
    Mitsuya H, Yarchoan R, Kageyama S, Broder S.
    FASEB J; 1991 Jul; 5(10):2369-81. PubMed ID: 1712326
    [Abstract] [Full Text] [Related]

  • 45. New developments in antiretroviral drug therapy for human immunodeficiency virus infections.
    Johnson VA, Hirsch MS.
    AIDS Clin Rev; 1990 Jul; ():235-72. PubMed ID: 1707295
    [No Abstract] [Full Text] [Related]

  • 46. The clinical applications of colony-stimulating factors in acquired immunodeficiency syndrome.
    Scadden DT.
    Semin Hematol; 1992 Oct; 29(4 Suppl 3):33-7. PubMed ID: 1492232
    [No Abstract] [Full Text] [Related]

  • 47. [Therapy and immunoprophylaxis of HIV infection].
    Vogt M, Täuber M.
    Ther Umsch; 1988 Sep; 45(9):611-8. PubMed ID: 3187915
    [No Abstract] [Full Text] [Related]

  • 48. Potent new AIDS drugs underscore promise of combination therapy.
    AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
    [Abstract] [Full Text] [Related]

  • 49. Combined zidovudine and interferon-alpha therapy in patients with Kaposi sarcoma and the acquired immunodeficiency syndrome (AIDS).
    Kovacs JA, Deyton L, Davey R, Falloon J, Zunich K, Lee D, Metcalf JA, Bigley JW, Sawyer LA, Zoon KC.
    Ann Intern Med; 1989 Aug 15; 111(4):280-7. PubMed ID: 2757312
    [Abstract] [Full Text] [Related]

  • 50. New developments in antiretroviral drug therapy for HIV infection.
    Johnson VA.
    AIDS Clin Rev; 1992 Aug 15; ():69-104. PubMed ID: 1318738
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. NIH conference. Antiretroviral therapy in AIDS.
    Broder S, Mitsuya H, Yarchoan R, Pavlakis GN.
    Ann Intern Med; 1990 Oct 15; 113(8):604-18. PubMed ID: 1698042
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. [A new AIDS drug in evaluation].
    Fortschr Med; 1993 Aug 30; 111(24):12. PubMed ID: 7691696
    [No Abstract] [Full Text] [Related]

  • 58. Treatment of CMV retinitis.
    Cox SW, Wahren B.
    N Engl J Med; 1992 Jun 18; 326(25):1701-2; author reply 1702-3. PubMed ID: 1534145
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.